42
Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Embed Size (px)

Citation preview

Page 1: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Abnormal LFTsMichele Ritter

Argy Resident – February, 2007

Page 2: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Liver Function Test Albumin Bilirubin:

Total Bilirubin Direct Bilirubin (conjugated bilirubin)

Serum aminotransferases Aspartate aminotransferase (AST) Alanine aminotransferase (ALT)

Alkaline Phosphatase Prothrombin time

Page 3: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Albumin Synthesized in the liver Production is controlled by multiple factors

including nutritional status, serum oncotic pressure, cytokines, and hormones

A serum albumin may be reflection of the synthetic function of the liver.

Page 4: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Bilirubin

Page 5: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Bilirubin Used to determine liver’s ability to clear

endogenous/exogenous substances from the circulation

Indirect (unconjugated) bilirubin Elevated with hemolysis, hepatic disease

Direct (conjugated) bilirubin Elevated with biliary obstruction and hepatocellular

disease. Jaundice usually develops with a bilirubin ≥ 3

mg/dL

Page 6: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Biliary Tract

Page 7: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Aminotransferases Hepatic enzymes that are usually

intracellular, but are released from hepatocytes with hepatocellular injury.

Includes aspartate aminotransferase (AST) and alanine aminotransferase (ALT)

AST/ALT ratio Normal is 0.8 In alcoholic hepatitis, is usually > 2

Page 8: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Alkaline Phosphatase A group of enzymes that catalyze the hydrolysis of a large

number of organic phosphate esters. In liver, believed to play an active role in down-regulating the

secretory activities of the intrahepatic biliary epithelium Found in:

Liver Bone intestine First trimester placenta Kidney

Gamma-glutamyl transpeptidase (GGT): Liver origin: Elevated GGT Bone origin: Normal GGT

Page 9: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Prothrombin Time (PT) Liver is in charge of the synthesis of many clotting

factors : Factor I (fibrinogen) Factor II (prothrombin) Factor V Factor VII Factor IX Factor X Factors XII and XIII

Elevated PT may be reflection of decreased synthetic activity of liver.

Page 10: Abnormal LFTs Michele Ritter Argy Resident – February, 2007
Page 11: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Assessing the patient with abnormal Liver Function Tests Most of the time, the cause of elevated LFTs can

be illicited without invasive testing (biopsy) If no cause of abnormality is found, most

frequently the cause is alcohol liver disease, steatosis, or steatohepatitis

Certain patterns exist with LFTs Hepatocellular Injury: Very high AST, ALT with

mild/moderately elevated alkaline phosphatase. Cholestatis: mild/moderately elevated AST/ALT with

very high alkaline phosphatase Bilirubin can be elevated with both combinations.

Page 12: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Medications:

History: Need to assess temporal relationship with drug, see if patient improves once medication removed

NSAIDs, antibiotics, statins, anti-tuberculosis medications, anti-epileptic drugs, acetaminophen

Frequently cause isolated elevated aminotransferases Acetaminophen overdose

Toxicity is likely to occur with single ingestions greater than 250 mg/kg or those greater than 12 g over a 24-hour period

AST/ALT elevations is first sign of liver damage (usually 24-hours after ingestion)

Alcohol Use: Frequently have AST:ALT ratio ≥ 2:1 History: Need accurate assessment of alcohol intake, including

CAGE questions.

Page 13: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Hepatitis A:

Acute infection History: travel, recent outbreak, MSM; nausea, vomiting, jaundice Labs: Hepatitis A IgM, frequent elevated bilirubin

Hepatitis B: Can be acute or chronic History: See if patient from Asia, Subsaharan Africa; Sexual history, Drug use Labs: Hepatitis B surface antigen, surface antibody, core antibody

Hepatitis C: History: IV drug abuse, blood transfusion prior to 1992, Sexual history, Tattoos Labs: Hepatitis C antibody (Hepatitis C viral load if HIV positive or

immunocompromised) HIV:

Often causes isolated elevated aminotransferases History: Sexual History, IV drug use Labs: HIV Antibody test (ELISA with reflex Western Blot)

Page 14: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Hereditary Hemochromatosis

History: Family history of liver disease? Diabetes? Heart Failure? Bronze skin?

Labs: Serum iron, TIBC

Calculate iron saturation = serum iron/TIBC If iron saturation > 45%, check ferritin

Ferritin If > 400 ng/mL in men, or > 300 ng/mL in women, then need to check

liver biopsy or genetic testing Liver biopsy

Homozygous hereditary hemochromatosis if iron index > 1.9 If under age 40, and positive genetic testing, no biopsy needed.

Genetic Testing

Page 15: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Hepatic steatosis/Non-alcoholic

steatohepatitis (NASH) Increase in AST/ALT are usually less than 4-fold. Ratio of AST/ALT is usually < 1 History: Female, obesity, diabetes Labs:

Labs to rule out other causes of hepatitis Abdominal Ultrasound: look for fatty infiltration of

liver

Page 16: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Autoimmune Hepatitis

History: Young to middle-aged female Labs:

Serum protein electrophoresis (SPEP) – if polyclonal increase in gamma globulin

Anti-nucleur antibody: Positive Anti-smooth-muscle antibody (SMA) Liver biopsy: should be performed if the above

are negative, but autoimmune hepatitis still suspected.

Page 17: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Alpha-1-antitrypsin deficiency History: Family history, emphysema,

young age Labs:

Alpha-1-antitrypsin level/phenotype Treatment:

Intravenous alpha-1 antiprotease helps with lung disease, but liver transplant is ultimately only treatment for liver disease.

Hepatocellular Injury

Page 18: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Wilson’s Disease

A genetic disorder of biliary copper excretion History: Age (usually age 5 – 25, but up to age 40), family

history of liver disease; neuropsychiatric disease Evaluation:

Serum ceruloplasmin: Low Opthalmologist: Exam for Kayser-Fleisher rings 24-hour urine copper Liver biopsy: Evaluate liver copper levels

Treatment: Copper chelating agents Zinc In some cases, ultimately liver transplant

Page 19: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Wilson’s Disease – Kayser-Fleisher Rings

Page 20: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Shock Liver (ischemic hepatitis)

Etiology: Shock, severe hypotension Severely elevated AST/ALT (50 times normal) Treatment: Re-establish good blood

pressure/perfusion. Prognosis: Usually patients recover, but can

progress to fulminant liver failure requiring transplant.

Page 21: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury Non-Hepatic Causes

Usually only mild increase in AST/ALT Muscle disorders Hypothyroidism/Hyperthyroidism Celiac Disease Adrenal Insufficiency Anorexia nervosa

Page 22: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Hepatocellular Injury What if work-up is negative and AST/ALT

remain elevated? Observe:

Patients with two-fold or less increase in AST/ALT and no hyperbilirubinemia

Liver Biopsy Patients with > two-fold increase in AST/ALT, or

abnormalities of other liver function tests.

Page 23: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Cholestatic Pattern Predominantly elevated alkaline phosphatase

Need to check GGT to see if bone or liver in origin

Blood types O and B: can have elevated serum alkaline phosphatase after eating a fatty meal due to an influx of intestinal alkaline phosphatase

Need to determine if the cholestasis is intrahepatic or extrahepatic in origin.

Page 24: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Cholestatic Pattern - Intrahepatic Drugs:

Anabolic steroids, contraceptives, antibiotics

Total parenteral nutrition (TPN) Cirrhosis:

Viral hepatitis (Hepatitis B, C) Alcohol hepatitis

Page 25: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Cholestatic Pattern - Intrahepatic Primary Biliary Cirrhosis

Autoimmune disease Predominately in women, usually ages 35-65 May have history of other autoimmune disease Symptoms: Prurutis, fatigue, hyperpigmentation,

musculoskeletal complaints Labs:

RUQ Ultrasound Anti-mitochondrial antibody Liver biopsy to verify diagnosis

Page 26: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Cholestatic Pattern – Both Intrahepatic and Extrahepatic

Primary Sclerosing Cholangitis chronic progressive disorder of unknown etiology that is characterized by

inflammation, fibrosis, and stricturing of medium size and large ducts in the intrahepatic and extrahepatic biliary tree

~ 90% have inflammatory bowel disease, especially ulcerative colitis Symptoms: Pruritus, fatigue, RUQ pain Diagnosis:

Ultrasound Cholangiogram: multifocal stricturing and dilation of intrahepatic and/or

extrahepatic bile ducts Prognosis:

Poor; average life expectancy after diagnosis is ~12 years 10-15% risk of developing cholangiocarcinoma Liver transplant is ultimate only treatment

Page 27: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Cholangiogram of Primary Sclerosing Cholangitis

Page 28: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Cholestatic Pattern - Extrahepatic Choledocholithiasis (gall stones!)

History: The 3 F’s RUQ colicky abdominal pain

Diagnosis/Treatment: Ultrasound, ERCP (to remove stones) Malignancy

Cholangiocarcinoma Pancreatic Metastatic cancer Diagnosis: Ultrasound, MRCP Treatment: ERCP, biliary stent

Page 29: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Cholestatic Pattern - Extrahepatic Chronic Pancreatitis

History: Recurrent pancreatitis Symptoms: Abdominal pain, frequently referred to back

HIV Cholangiopathy Usually seen in AIDS patients with CD4 count well below

100/mm3

Usually caused by: Cryptosporidium. Microsporidium, CMV Symptoms: RUQ pain, Diarrhea, Occassional fever,

Occassional jaundice Diagnosis:

ERCP Cholangiography – shows multifocal strictures of extrahepatic

biliary tree

Page 30: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Isolated Hyperbilirubinemia Unconjugated (indirect) hyperbilirubinemia

Overproduction of bilirubin Hemolysis Dubin-Johnson Syndrome and Rotor Syndrome

Decrease in uptake, conjugation, or excretion of bilirubin

Increased unconjugated (indirect) bilirubin Liver Disease

Page 31: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Isolated Unconjugated Hyperbilirubinemia Drugs

Probenecid, Rifampicin Gilbert’s Disease

Autosomal recessive disorder 3 to 7 % of population Most common in white males Jaundice, increased unconjugated bilirubin (always < 6) Occurs when patient under stress/infection

Crigler-Najjar type II Caused by gene mutation Reduced activity of Bilirubin UDP glucuronosyl

Page 32: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

SUMMARY Hepatocellular Injury –

mostly AST/ALT Drugs Alcohol hepatitis Hepatitis A Hepatitis B Hepatitis C Steatohepatitis (NASH)

Autoimmune hepatitis Wilson’s Disease Hereditary

Hemochromatosis Alpha-1 antitrypsin

deficiency

Page 33: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

SUMMARY

EXTRAHEPATIC Gall stones Primary Sclerosing

Cholangitis Malignancy Chronic pancreatitis HIV cholangiopathy

Cholestatic Pattern INTRAHEPATIC

Drugs Hepatitis A, B, C Alcoholic hepatitis TPN Primary Sclerosing

Cholangitis Primary Biliary Cirrhosis

Page 34: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

SUMMARY Isolated elevated indirect (unconjugated)

bilirubin Hemolysis Drugs Gilbert’s Disease Crigler-Najjar type II

Page 35: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario # 1 A 43-year old woman who has consumed a pint of

80-proof whiskey daily for 18 years presents with right upper quadrant pain. The pain began approximately a week ago and has been transiently relieved by her taking two extra-strength acetaminophen tablets every 4 hours for the past 4 days. She has had some nausea and vomiting but no fever. There is no history of jaundice or cholelithiasis. The patient used intravenous drugs and shared needles during her late teen years.

Page 36: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario # 1 Physical Exam

Enlarged tender liver that percusses to 17 cm in the right midclavicular line and a tattoo on the right buttock

Labs: Bilirubin: 2 mg/dL AST: 3800 Alk. Phos: 198 PT: normal

Page 37: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario #1 The most likely diagnosis is:

(A) Alcoholic hepatitis

(B) Acute cholecystitis

(C) Acetaminophen hepatotoxicity

(D) Acute viral hepatitis B

(E) Acute viral hepatitis C

Page 38: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario # 2 A 54-year old asymptomatic man volunteers to

donate blood and is found to have elevated aminotransferase levels. He has no known medical problems and no history of hepatitis. He drinks no alcohol, takes no medications, and has not seen a physician in more than 10 years. He is active, works as a truck driver, and has noted no change in his physical condition. He has no family history of liver disease.

Page 39: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario # 2 Physical Exam:

Obesity – Ht: 5’ 10”, 115 kg Labs:

AST: 45 ALT: 85 Alk. Phos: 90 Hepatitis serologies (A, B, C): negative ESR: normal ANA: negative Smooth muscle antibody: negatie Total chol: 260 LDL; 225 Triglycerides: 830

Liver biopsy: Large-droplet steatosis without significant inflammatory reaction

and no fibrosis. Ultrasonography shows a mildly enlarged fatty liver.

Page 40: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario # 2 The appropriate management of this patient

would be:(A) Interferon therapy for presumed chronic non-B, non-C

hepatitis

(B) Alcohol rehabilitation and counseling

(C) Weight loss and therapy for hyperlipidemia

(D) Endoscopic retrograde cholangiopancreatography (ERCP) to evaluate the biliary tree

(E) Corticosteroid therapy

Page 41: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario # 3 A 43-year old woman complains of itching that

keeps her awake at night. Physical examination is normal except for the liver, which is felt 7 cm below the right costal margin.

CBC is normal Creatinine: 0.8 mg/dL, Bilirubin: 0.6 mg/dL ALT: 78 U/L, Albumin: 4.2 g/dL Alkaline Phosphatase: 450 U/L Cholangiogram: normal

Page 42: Abnormal LFTs Michele Ritter Argy Resident – February, 2007

Scenario # 3 Which test would be most accurate in

diagnosing her underlying disorder?(A) Serum protein electrophoresis

(B) Anti-Smooth Muscle Antibody

(C) Antimitochondrial antibody

(D) Technetium-99m liver-spleen scan

(E) Endoscopic retrograde cholangiopancreatography (ERCP)